DNTH
Price
$27.96
Change
+$1.96 (+7.54%)
Updated
Sep 19, 10:10 AM (EDT)
IMNM
Price
$15.73
Change
+$0.23 (+1.48%)
Updated
Sep 19, 10:26 AM (EDT)
53 days until earnings call
Ad is loading...

DNTH vs IMNM

Header iconDNTH vs IMNM Comparison
Open Charts DNTH vs IMNMBanner chart's image
Dianthus Therapeutics
Price$27.96
Change+$1.96 (+7.54%)
Volume$400
CapitalizationN/A
Immunome
Price$15.73
Change+$0.23 (+1.48%)
Volume$1.33K
CapitalizationN/A
View a ticker or compare two or three
DNTH vs IMNM Comparison Chart
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
DNTH vs. IMNM commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and IMNM is a Buy.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (DNTH: $26.00 vs. IMNM: $15.50)
Brand notoriety: DNTH and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 82% vs. IMNM: 148%
Market capitalization -- DNTH: $762.92M vs. IMNM: $930.84M
DNTH [@Biotechnology] is valued at $762.92M. IMNM’s [@Biotechnology] market capitalization is $930.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $599.73B to $0. The average market capitalization across the [@Biotechnology] industry is $3.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 1 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 1 green, 4 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 4 TA indicator(s) are bullish while IMNM’s TA Score has 7 bullish TA indicator(s).

  • DNTH’s TA Score: 4 bullish, 5 bearish.
  • IMNM’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а -5.69% price change this week, while IMNM (@Biotechnology) price change was +7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +7.58%, and the average quarterly price growth was +1.88%.

Reported Earning Dates

DNTH is expected to report earnings on Nov 09, 2023.

IMNM is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($931M) has a higher market cap than DNTH($763M). DNTH YTD gains are higher at: 150.000 vs. IMNM (44.860). DNTH (-68.36M) and IMNM (-71.17M) have comparable annual earnings (EBITDA) . DNTH has more cash in the bank: 361M vs. IMNM (278M). DNTH has less debt than IMNM: DNTH (407K) vs IMNM (2.77M). IMNM has higher revenues than DNTH: IMNM (10.8M) vs DNTH (4.12M).
DNTHIMNMDNTH / IMNM
Capitalization763M931M82%
EBITDA-68.36M-71.17M96%
Gain YTD150.00044.860334%
P/E RatioN/AN/A-
Revenue4.12M10.8M38%
Total Cash361M278M130%
Total Debt407K2.77M15%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
33
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
42

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHIMNM
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBLEX14.79-0.02
-0.14%
Fidelity Series Stk Selec Lg Cp Val
LMEAX18.38-0.06
-0.33%
Franklin International Equity A
HLGZX43.56-0.16
-0.37%
Harding Loevner Global Equity Instl Z
RIVJX17.60-0.07
-0.40%
American Funds International Vntg R-5E
FULVX12.32-0.07
-0.56%
Fidelity U.S. Low Volatility Equity

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with ANNX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then ANNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
+0.04%
ANNX - DNTH
37%
Loosely correlated
-1.14%
IMNM - DNTH
36%
Loosely correlated
+0.65%
CRNX - DNTH
34%
Loosely correlated
-0.42%
MGTX - DNTH
34%
Loosely correlated
+0.47%
PRTA - DNTH
31%
Poorly correlated
-2.10%
More

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with TNYA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then TNYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
+0.65%
TNYA - IMNM
40%
Loosely correlated
-2.42%
XNCR - IMNM
39%
Loosely correlated
-0.81%
KOD - IMNM
37%
Loosely correlated
-1.12%
DNTH - IMNM
36%
Loosely correlated
+0.04%
ATXS - IMNM
36%
Loosely correlated
+1.22%
More